Javascript must be enabled to continue!
Commentary on the NICE guideline on renal replacement therapy and conservative management
View through CrossRef
Abstract
Background
NICE Guideline NG107, “Renal replacement therapy and conservative management” (Renal replacement therapy and conservative management (NG107); 2018:1–33) was published in October 2018 and replaced the existing NICE guideline CG125, “Chronic Kidney Disease (Stage 5): peritoneal dialysis” (Chronic kidney disease (stage 5): peritoneal dialysis | Guidance | NICE; 2011) and NICE Technology Appraisal TA48, “Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure”(Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure (Technology appraisal guideline TA48); 2002) The aim of the NICE guideline (NG107) was to provide guidance on renal replacement therapy (RRT), including dialysis, transplant and conservative care, for adults and children with CKD Stages 4 and 5. The guideline is extremely welcomed by the Renal Association and it offers huge value to patients, clinicians, commissioners and key stakeholders. It overlaps and enhances current guidance published by the Renal Association including “Haemodialysis” (Clinical practice guideline: Haemodialysis; 2019) which was updated in 2019 after the publication of the NICE guideline, “Peritoneal Dialysis in Adults and Children” (Clinical practice guideline: peritoneal Dialysis in adults and children; 2017) and “Planning, Initiation & withdrawal of Renal Replacement Therapy” (Clinical practice guideline: planning, initiation and withdrawal of renal replacement therapy; 2014) (at present there are no plans to update this guideline).
There are several strengths to NICE guideline NG107 and we agree with and support the vast majority of recommendation statements in the guideline. This summary from the Renal Association discusses some of the key highlights, controversies, gaps in knowledge and challenges in implementation. Where there is disagreement with a NICE guideline statement, we have highlighted this and a new suggested statement has been written.
Springer Science and Business Media LLC
Title: Commentary on the NICE guideline on renal replacement therapy and conservative management
Description:
Abstract
Background
NICE Guideline NG107, “Renal replacement therapy and conservative management” (Renal replacement therapy and conservative management (NG107); 2018:1–33) was published in October 2018 and replaced the existing NICE guideline CG125, “Chronic Kidney Disease (Stage 5): peritoneal dialysis” (Chronic kidney disease (stage 5): peritoneal dialysis | Guidance | NICE; 2011) and NICE Technology Appraisal TA48, “Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure”(Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure (Technology appraisal guideline TA48); 2002) The aim of the NICE guideline (NG107) was to provide guidance on renal replacement therapy (RRT), including dialysis, transplant and conservative care, for adults and children with CKD Stages 4 and 5.
The guideline is extremely welcomed by the Renal Association and it offers huge value to patients, clinicians, commissioners and key stakeholders.
It overlaps and enhances current guidance published by the Renal Association including “Haemodialysis” (Clinical practice guideline: Haemodialysis; 2019) which was updated in 2019 after the publication of the NICE guideline, “Peritoneal Dialysis in Adults and Children” (Clinical practice guideline: peritoneal Dialysis in adults and children; 2017) and “Planning, Initiation & withdrawal of Renal Replacement Therapy” (Clinical practice guideline: planning, initiation and withdrawal of renal replacement therapy; 2014) (at present there are no plans to update this guideline).
There are several strengths to NICE guideline NG107 and we agree with and support the vast majority of recommendation statements in the guideline.
This summary from the Renal Association discusses some of the key highlights, controversies, gaps in knowledge and challenges in implementation.
Where there is disagreement with a NICE guideline statement, we have highlighted this and a new suggested statement has been written.
Related Results
Us Public Health Service Clinical Practice Guideline: Treating Tobacco Use and Dependence
Us Public Health Service Clinical Practice Guideline: Treating Tobacco Use and Dependence
Treating Tobacco Use and Dependence, a Public Health Service-sponsored Clinical Practice Guideline, is a product of the Tobacco Use and Dependence Guideline Panel ("the panel"), co...
Divergent Conceptualizations and Management Strategies for Neurogenic Thoracic Outlet Syndrome: A Qualitative Multispecialty Study
Divergent Conceptualizations and Management Strategies for Neurogenic Thoracic Outlet Syndrome: A Qualitative Multispecialty Study
Abstract
Background
Neurogenic thoracic outlet syndrome (nTOS) is the most prevalent subtype of thoracic outlet syndrome and remains one of the most controversial conditions in per...
Renal serotonin signaling in ischemic kidney insufficiency
Renal serotonin signaling in ischemic kidney insufficiency
Renal ischemia–reperfusion (IR) injury is a major cause of acute kidney injury (AKI), a syndrome associated with high morbidity, mortality, and long-term risk of chronic kidney dis...
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
BackgroundA clinical dilemma exists in patients with CKD, ESKD, and after kidney transplantation, as they face concurrent risks of both thromboembolic and hemorrhagic complications...
ASSA13-14-12 Association of Renal Artery Variations and Renal Artery Stenosis, Impaired Renal Function, Plasma Renin Activity
ASSA13-14-12 Association of Renal Artery Variations and Renal Artery Stenosis, Impaired Renal Function, Plasma Renin Activity
Objectives
To compare the prevalence of hemodynamically significant stenosis between renal arteries with and without variations in resistant hypertensive patients...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Renal T1 times reference values to improve risk stratification in patients with concomitant cardiac and renal disease: A 1.5 T CMR study
Renal T1 times reference values to improve risk stratification in patients with concomitant cardiac and renal disease: A 1.5 T CMR study
Abstract
Background
Multiparametric imaging is well established in cardiac disease, but less is known about its value in ...
Conservative therapy is associated with worse clinical features and biochemical derangements than renal replacement therapy: a retrospective study in Kumasi, Ghana
Conservative therapy is associated with worse clinical features and biochemical derangements than renal replacement therapy: a retrospective study in Kumasi, Ghana
Abstract
Background
The incidence of end stage kidney disease (ESKD) is increasing in Ghana as with the rest of the world. This study compared the s...

